Press Releases

Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC) has been awarded first place in the Excipients/Non-Actives category at the 2025 NIE New Ingredient Awards,

Roquette showcases technical expertise with 14 poster presentations and four speaker sessions to meet the evolving needs of pharmaceutical developers.

The Health & Pharma Solutions facility offers state-of-the-art laboratory and training rooms for customers, as part of Roquette’s new Pharmaceutical Innovation Center in São Paulo, to strengthen Latin America as a collaborative hub for health and pharma solutions.

Showcasing the combined strength of Roquette’s Health & Pharma Solutions’ capabilities in excipients, capsules, APIs, and drug delivery technologies at CPhI 2025.

Roquette Boosts Extensive Cyclodextrins Portfolio with Launch of KLEPTOSE® Crysmeb Methyl-Beta-Cyclodextrin for Oral and Parenteral Formulations.

This strategic milestone marks a significant step forward in Roquette's ambition to become a leader in support of the global pharma markets.

Roquette launches a new coatings platform, combining cutting-edge performance with eco-consciousness, designed to meet the growing demand in prescription pharmaceutical, nutraceutical, and OTC markets. 

Roquette launches of its new LYCAGEL® Flex hydroxypropyl pea starch premix for nutraceutical and pharmaceutical softgel capsules.

Roquette to Spotlight Pea Starch Technology at booth K148, Vitafoods Europe, Geneva, Switzerland, 14-16 May 2024.

Roquette takes decisive strategic step and signs agreement to Acquire IFF Pharma Solutions. The family-owned company becomes a reference player in drug delivery solutions globally.

At CPHI Barcelona, Roquette unveiles three new excipient grades for moisture sensitive active pharmaceutical and nutraceutical ingredients. 

The Group Reinforces Its Global Position in the Pharmaceutical Industry. This strategic investment creates a stronger leader, with an expanded global footprint, as well as an enriched offering of oral dosage solutions.

Roquette is set to unveil its extensive range of excipients for moisture protection – including three new product grades – at CPHI Barcelona next month. 

With this acquisition of renowned producer of hard capsules and pharmaceutical processing equipment for oral dosage, Roquette aims at reinforcing its global position in the pharmaceutical industry.

Roquette Announces Strategic Investment and Innovation Agreement with Beren Therapeutics P.B.C.